GENEVA, March 23 -- ONCOPEPTIDES AB (Luntmakargatan 46111037 Stockholm) filed a patent application (PCT/EP2025/076122) for "BIS-CHLOROETHYLAMINO DERIVATIVES FOR TREATING LEUKEMIA" on Sep 12, 2025. With publication no. WO/2026/057823, the details related to the patent application was published on Mar 19, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ACS, Klara (Stockholm), SVENSSON GELIUS, Stefan (Stockhom)
Abstract: The invention provides compounds of formula (I), that are peptidase enhanced cytotoxics for use for use in the treatment of and/or prophylaxis of BCL2 inhibitor resistant or r...